Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide

被引:69
|
作者
Ciardiello, F
Caputo, R
Bianco, R
Damiano, V
Pomatico, G
Pepe, S
Bianco, AR
Agrawal, S
Mendelsohn, J
Tortora, G
机构
[1] Univ Naples Federico II, Fac Med & Chirurg, Cattedra Oncol Med, Dipartimento Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy
[2] Hybridon Inc, Cambridge, MA USA
[3] Univ Texas, Md Anderson Canc Ctr, Houston, TX USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 14期
关键词
D O I
10.1093/jnci/90.14.1087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The expression of epidermal growth factor receptor (EGFR) and type I cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKAI) is associated with neoplastic transformation. By use of human renal cancer cell lines (i,e,, 769-P, ACHN, A498, and SW839), we investigated the antiproliferative activity and the antitumor activity of an anti-EGFR humanized chimeric mouse monoclonal antibody, MAb C225, and a novel mixed backbone 18-mer antisense oligonucleotide, HYB 190, that targets expression of the RI alpha regulatory subunit of PKAI, Methods: The antiproliferative activity of MAb C225 and oligonucleotide HYB 190, alone or in combination, on different renal cancer cell lines was determined by monitoring cell growth in soft agar, In addition, the induction of apoptosis by treatment with the anti-EGFR antibody and/or antisense PKAI oligonucleotides was evaluated by flow cytometric analysis of fragmented DNA, The antitumor activity of MAb C225 and oligonucleotide HYB 190 was determined in athymic mice bearing established ACHN tumor xenografts, Cell proliferation and tumor growth data were evaluated for statistical significance using Student's t test; reported P values are two-sided. Results: MAb C225 and oligonucleotide HYB 190 inhibited colony formation in soft agar in a dose-dependent manner for all renal cancer cell lines tested, We observed a potentiation of growth inhibition and induction of apoptosis when 769-P cells and ACHN cells were treated with both agents. Combination treatment with MAb C225 and oligonucleotide HYB 190 caused regression of ACHN tumor xenografts, whereas single-agent treatment only delayed tumor growth. Conclusion: The combination of anti-EGFR MAb C225 and HYB 190 antisense PKAI oligonucleotides HYB 190 exhibited cooperative antiproliferative effects and cooperative antitumor effects on EGFR and PKAI-expressing human renal cancer cell Lines.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [21] Development of an affinity-matured humanized anti-epidermal growth factor receptor antibody for cancer immunotherapy
    Nakanishi, Takeshi
    Maru, Takamitsu
    Tahara, Kazuhiro
    Sanada, Hideaki
    Umetsu, Mitsuo
    Asano, Ryutaro
    Kumagai, Izumi
    PROTEIN ENGINEERING DESIGN & SELECTION, 2013, 26 (02): : 113 - 122
  • [22] Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer
    Akiko Kubo
    Hironobu Hashimoto
    Naoki Takahashi
    Yasuhide Yamada
    World Journal of Gastroenterology, 2016, (02) : 887 - 894
  • [23] Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer
    Kubo, Akiko
    Hashimoto, Hironobu
    Takahashi, Naoki
    Yamada, Yasuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) : 887 - 894
  • [24] The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer
    Bouche, Olivier
    Beretta, Giordano Domenico
    Garcia Alfonso, Pilar
    Geissler, Michael
    CANCER TREATMENT REVIEWS, 2010, 36 : S1 - S10
  • [25] Feedback inhibition of epidermal growth factor receptor by protein kinase A
    Barbier, AJ
    Poppleton, HM
    Mullenix, JB
    Patel, TB
    FASEB JOURNAL, 1997, 11 (09): : A1354 - A1354
  • [26] Anti-epidermal growth factor receptor tyrosine kinase activities of traditional Chinese medicine for cancer treatment
    Wang, Zenghui
    Lin, Sensen
    Wang, Dongmei
    Huang, Linfang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (05) : 565 - 570
  • [27] Panitumumab, a monoclonal anti-epidermal growth factor receptor antibody in colorectal cancer: Another one or the one?
    Messersmith, Wells A.
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4664 - 4666
  • [28] Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
    Kendall, Anne
    Lord, Rosemary
    Maisey, Nick
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (02) : 142 - 151
  • [29] THE ROLE OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES IN HEAD AND NECK CANCER
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 57 - 57
  • [30] Inhibition of Epidermal Growth Factor Receptor Signaling by Antisense Oligonucleotides as a Novel Approach to Epidermal Growth Factor Receptor Inhibition
    Madanayake, Thushara W.
    Welsh, Eric A.
    Darville, Lancia N. F.
    Koomen, John M.
    Chalfant, Charles E.
    Haura, Eric B.
    Robinson, Timothy J.
    NUCLEIC ACID THERAPEUTICS, 2022, 32 (05) : 391 - 400